Vendor, San Antonio, TX
Gryphon Bio Inc.
UEI GNX8BTRL8915, CAGE 84CH5
1 award and $0 obligated between October 23, 2024 and February 10, 2026, 100% under full and open competition, against 102.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W81XWH22C0059Definitive Contract, October 23, 2024, Full and Open Competition, 102 offers | Army Med Res Acq ActivityDefense Health Agency | Feasibility Study of a Single Platform Solution for Blood Testing of Traumatic Brain Injury Biomarkers.NAICS 541715, PSC AN12 | $0 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 3 across 1 awards